IRIS Accounts Production v24.3.2.46 11449937 Board of Directors Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh114499372023-04-30114499372024-04-30114499372023-05-012024-04-30114499372022-04-30114499372022-05-012023-04-30114499372023-04-3011449937ns15:EnglandWales2023-05-012024-04-3011449937ns14:PoundSterling2023-05-012024-04-3011449937ns10:Director12023-05-012024-04-3011449937ns10:Director22023-05-012024-04-3011449937ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3011449937ns10:SmallEntities2023-05-012024-04-3011449937ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3011449937ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3011449937ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3011449937ns10:FullAccounts2023-05-012024-04-3011449937ns10:OrdinaryShareClass12023-05-012024-04-3011449937ns10:RegisteredOffice2023-05-012024-04-3011449937ns5:CurrentFinancialInstruments2024-04-3011449937ns5:CurrentFinancialInstruments2023-04-3011449937ns5:ShareCapital2024-04-3011449937ns5:ShareCapital2023-04-3011449937ns5:RetainedEarningsAccumulatedLosses2024-04-3011449937ns5:RetainedEarningsAccumulatedLosses2023-04-3011449937ns5:PlantMachinery2023-05-012024-04-3011449937ns5:PlantMachinery2023-04-3011449937ns5:PlantMachinery2024-04-3011449937ns5:PlantMachinery2023-04-3011449937ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3011449937ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3011449937ns5:WithinOneYear2024-04-3011449937ns5:WithinOneYear2023-04-3011449937ns5:BetweenOneFiveYears2024-04-3011449937ns5:BetweenOneFiveYears2023-04-3011449937ns5:AllPeriods2024-04-3011449937ns5:AllPeriods2023-04-3011449937ns10:OrdinaryShareClass12024-04-30114499371ns10:Director12023-04-30114499371ns10:Director12022-04-30114499371ns10:Director12023-05-012024-04-30114499371ns10:Director12022-05-012023-04-30114499371ns10:Director12024-04-30114499371ns10:Director12023-04-30
REGISTERED NUMBER: 11449937 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

FOR

STIRLING HEALTHCARE (CAMBRIDGE) LTD

STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


STIRLING HEALTHCARE (CAMBRIDGE) LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: G M Mullane
M A Sumner





REGISTERED OFFICE: 10 Jesus Lane
Cambridge
United Kingdom
CB5 8BA





BUSINESS ADDRESS: Suite F8 Stirling House
Cambridge Innovation Park
Waterbeach
Cambridgeshire
CB25 9GL





REGISTERED NUMBER: 11449937 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 40,505 54,008

CURRENT ASSETS
Debtors 6 175,952 121,823
Cash at bank and in hand 412 2,859
176,364 124,682
CREDITORS
Amounts falling due within one year 7 (1,733,169 ) (1,489,575 )
NET CURRENT LIABILITIES (1,556,805 ) (1,364,893 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,516,300 ) (1,310,885 )

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings (1,516,400 ) (1,310,985 )
SHAREHOLDERS' FUNDS (1,516,300 ) (1,310,885 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)

BALANCE SHEET - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 December 2024 and were signed on its behalf by:




G M Mullane - Director



M A Sumner - Director


STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Stirling Healthcare (Cambridge) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
At the balance sheet date liabilities exceeded assets by £1,516,300 (2022: £1,310,885). The financial statements have been prepared on a going concern basis as the company continues to receive the support of its director.

Turnover
Turnover represents receivable sale of community care services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 15, 25%, 33% on reducing balance

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 2 ) .

STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023
and 30 April 2024 189,513
DEPRECIATION
At 1 May 2023 135,505
Charge for year 13,503
At 30 April 2024 149,008
NET BOOK VALUE
At 30 April 2024 40,505
At 30 April 2023 54,008

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,167 -
Amounts owed by group undertakings 48,000 48,000
Other debtors 126,785 73,823
175,952 121,823

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 74,735 55,860
Amounts owed to group undertakings 1,655,058 1,432,670
Taxation and social security 40 -
Other creditors 3,336 1,045
1,733,169 1,489,575

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 60,000 72,000
Between one and five years - 60,000
60,000 132,000

STIRLING HEALTHCARE (CAMBRIDGE) LTD (REGISTERED NUMBER: 11449937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
G M Mullane
Balance outstanding at start of year - -
Amounts advanced 5,375 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 5,375 -